Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of April 2, 2025 • 1:21 PM ET
As of April 2, 2025 • 1:21 PM ET
Date/Time | Source | News Release |
---|---|---|
03/31/2025 10:48 AM EDT | SeekingAlpha | Brainstorm Cell Therapeutics Inc. (BCLI) Q4 2024 Earnings Call Transcript |
03/31/2025 07:05 AM EDT | SeekingAlpha | BrainStorm Cell Therapeutics GAAP EPS of -$2.31 |
03/31/2025 07:00 AM EDT | US Earnings Reports | Expected US Company Earnings on Monday, March 31st, 2025 |
03/31/2025 05:30 AM EDT | US Earnings Reports | Expected earnings - Brainstorm Cell Therapeutics Inc. |
03/28/2025 12:45 PM EDT | SeekingAlpha | BrainStorm Cell Therapeutics Q4 2024 Earnings Preview |
03/26/2025 08:30 AM EDT | SeekingAlpha | BrainStorm Cell Therapeutics receives Nasdaq compliance extension |
11/14/2024 05:03 PM EST | SeekingAlpha | BrainStorm Cell Therapeutics GAAP EPS of -$1.80 |
11/13/2024 04:36 AM EST | US Earnings Reports | Expected earnings - Brainstorm Cell Therapeutics Inc. |
10/30/2024 06:11 AM EDT | SeekingAlpha | BrainStorm Cell Therapeutics regains compliance with Nasdaq |
10/01/2024 09:01 AM EDT | KlickAnalytics | BCLI announced stock split 1-15 |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.